- Home
- HURA vs ANIK Comparison
HURA vs ANIK Comparison
Compare HURA & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- ANIK
- Stock Information
- Founded
- HURA 2009
- ANIK 1983
- Country
- HURA United States
- ANIK United States
- Employees
- HURA N/A
- ANIK N/A
- Industry
- HURA
- ANIK Medical/Dental Instruments
- Sector
- HURA
- ANIK Health Care
- Exchange
- HURA Nasdaq
- ANIK Nasdaq
- Market Cap
- HURA 171.7M
- ANIK 196.6M
- IPO Year
- HURA N/A
- ANIK 1993
- Fundamental
- Price
- HURA $2.72
- ANIK $11.55
- Analyst Decision
- HURA Strong Buy
- ANIK Buy
- Analyst Count
- HURA 2
- ANIK 1
- Target Price
- HURA $11.50
- ANIK $19.00
- AVG Volume (30 Days)
- HURA 132.5K
- ANIK 69.6K
- Earning Date
- HURA 06-17-2025
- ANIK 08-07-2025
- Dividend Yield
- HURA N/A
- ANIK N/A
- EPS Growth
- HURA N/A
- ANIK N/A
- EPS
- HURA N/A
- ANIK N/A
- Revenue
- HURA N/A
- ANIK $117,053,000.00
- Revenue This Year
- HURA N/A
- ANIK N/A
- Revenue Next Year
- HURA $69.15
- ANIK $9.70
- P/E Ratio
- HURA N/A
- ANIK N/A
- Revenue Growth
- HURA N/A
- ANIK 4.61
- 52 Week Low
- HURA $1.80
- ANIK $10.89
- 52 Week High
- HURA $13.13
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- HURA N/A
- ANIK 41.90
- Support Level
- HURA N/A
- ANIK $11.17
- Resistance Level
- HURA N/A
- ANIK $11.92
- Average True Range (ATR)
- HURA 0.00
- ANIK 0.39
- MACD
- HURA 0.00
- ANIK 0.11
- Stochastic Oscillator
- HURA 0.00
- ANIK 55.93
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.